+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
New

Europe Veterinary Pharmaceuticals Market Size, Share & Trends Analysis Report 2026-2033

  • PDF Icon

    Report

  • 145 Pages
  • October 2026
  • Region: Europe
  • Grand View Research
  • ID: 5450204
The Europe veterinary pharmaceuticals market size was valued at USD 7.9 billion in 2025 and is projected to grow from USD 8.6 billion in 2026 to USD 17.1 billion by 2033, at a CAGR of 10.3% from 2026 to 2033. The growing awareness about zoonoses, the humanization of pets, the availability of pet insurance, and R&D initiatives by market players are the key factors anticipated to fuel market growth in the coming years.

Europe Veterinary Pharmaceuticals Market Report Segmentation

This report forecasts revenue growth at country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, the analyst has segmented the Europe veterinary pharmaceuticals market report based on animal type, product, drug type, type, route of administration, sales channel, and country.

Animal Outlook (Revenue, USD Million, 2021 - 2033)

  • Production Animals
  • Poultry
  • Swine
  • Bovine
  • Ovine & Caprine
  • Others
  • Companion Animals
  • Canine
  • Feline
  • Equine
  • Others

Product Outlook (Revenue, USD Million, 2021 - 2033)

  • Parasiticides
  • Anti-infectives
  • Anti-inflammatory
  • Analgesics
  • Other Products

Drug Type Outlook (Revenue, USD Million, 2021 - 2033)

  • Branded
  • Generics

Type Outlook (Revenue, USD Million, 2021 - 2033)

  • Prescription
  • OTC

Route of Administration Outlook (Revenue, USD Million, 2021 - 2033)

  • Oral
  • Injectable
  • Topical
  • Other Routes

Sales Channel Outlook (Revenue, USD Million, 2021 - 2033)

  • Institutional Sales
  • Veterinary Pharmacies & Retail
  • E-Commerce
  • Other Channels

Regional Outlook (Revenue, USD Million, 2021 - 2033)

  • UK
  • Germany
  • France
  • Italy
  • Spain
  • Denmark
  • Sweden
  • Norway

Why should you buy this report?

  • Comprehensive Market Analysis: Gain detailed insights into the market across major regions and segments.
  • Competitive Landscape: Explore the market presence of key players.
  • Future Trends: Discover the pivotal trends and drivers shaping the future of the market.
  • Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.

This report addresses:

  • Market intelligence to enable effective decision-making
  • Market estimates and forecasts from 2018 to 2030
  • Growth opportunities and trend analyses
  • Segment and regional revenue forecasts for market assessment
  • Competition strategy and market share analysis
  • Product innovation listing for you to stay ahead of the curve

Table of Contents

Chapter 1. Research Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Animal
1.2.2. Product
1.2.3. Drug Type
1.2.4. Type
1.2.5. Route of Administration
1.2.6. Sales Channel
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased Database
1.4.2. The internal database
1.4.3. Secondary Sources
1.4.4. Primary Research
1.5. Model Details
1.5.1. Commodity Flow Analysis
1.5.2. Top-Down Analysis
1.5.3. Bottom-up Approach
1.5.4. Multivariate Analysis
1.6. Information or Data Analysis
1.6.1. Data Analysis Models
1.7. Market Formulation & Validation
1.8. List of Secondary Sources
1.9. List of Abbreviations
1.10. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights
Chapter 3. Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Related/Ancillary Market Outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.1.1. Growing Pet Ownership and Increasing Demand for Preventive Veterinary Healthcare
3.2.1.2. Rising Incidence of Livestock Diseases and Cross-Border Disease Outbreaks
3.2.1.3. Growing Focus on Livestock Productivity, Food Safety, and Animal Welfare
3.2.1.4. Expanding Need for Veterinary Parasite Control
3.2.2. Market Restraint Analysis
3.2.2.1. Veterinary Medicine Shortages and Supply Chain Disruptions
3.2.2.2. High Regulatory Compliance Costs and Stringent Veterinary Drug Approval Requirements
3.2.3. Market Opportunity Analysis
3.2.4. Market Challenge Analysis
3.3. Technology Landscape
3.4. Pricing Analysis, 2025
3.5. Tariff Impact Analysis
3.6. Value Chain Analysis
3.6.1. Supply Trends
3.6.2. Demand Trends
3.7. Market Analysis Tools
3.7.1. Porter’s Five Force Analysis
3.7.2. PESTEL Analysis
Chapter 4. Europe Veterinary Pharmaceuticals Market: Animal Estimates & Trend Analysis
4.1. Europe Veterinary Pharmaceuticals Market, Animal: Segment Dashboard
4.2. Europe Veterinary Pharmaceuticals Market, Animal: Movement Analysis
4.3. Europe Veterinary Pharmaceuticals Market Estimates & Forecasts, Animal, 2021 - 2033 (USD Million)
4.4. Production Animals
4.4.1. Production Animals Market Estimates and Forecasts, 2021 - 2033 (USD Million)
4.4.2. Poultry
4.4.2.1. Poultry Market Estimates and Forecasts, 2021 - 2033 (USD Million)
4.4.3. Swine
4.4.3.1. Swine Market Estimates and Forecasts, 2021 - 2033 (USD Million)
4.4.4. Bovine
4.4.4.1. Bovine Market Estimates and Forecasts, 2021 - 2033 (USD Million)
4.4.5. Ovine & Caprine
4.4.5.1. Ovine & Caprine Market Estimates and Forecasts, 2021 - 2033 (USD Million)
4.4.6. Others
4.4.6.1. Others Market Estimates and Forecasts, 2021 - 2033 (USD Million)
4.5. Companion Animals
4.5.1. Companion Animals Market Estimates and Forecasts, 2021 - 2033 (USD Million)
4.5.2. Canine
4.5.2.1. Canine Animals Market Estimates and Forecasts, 2021 - 2033 (USD Million)
4.5.3. Feline
4.5.3.1. Feline Animals Market Estimates and Forecasts, 2021 - 2033 (USD Million)
4.5.4. Equine
4.5.4.1. Equine Animals Market Estimates and Forecasts, 2021 - 2033 (USD Million)
4.5.5. Others
4.5.5.1. Others Animals Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Chapter 5. Europe Veterinary Pharmaceuticals Market: Product Estimates & Trend Analysis
5.1. Europe Veterinary Pharmaceuticals Market, Product: Segment Dashboard
5.2. Europe Veterinary Pharmaceuticals Market, Product Movement Analysis
5.3. Europe Veterinary Pharmaceuticals Market Estimates & Forecasts, Product, 2021 - 2033 (USD Million)
5.4. Parasiticides
5.4.1. Parasiticides Market Estimates and Forecasts, 2021 - 2033 (USD Million)
5.5. Anti-infective
5.5.1. Anti-infective Market Estimates and Forecasts, 2021 - 2033 (USD Million)
5.6. Anti-inflammatory
5.6.1. Anti-inflammatory Market Estimates and Forecasts, 2021 - 2033 (USD Million)
5.7. Analgesics
5.7.1. Analgesics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
5.8. Other Products
5.8.1. Other Products Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Chapter 6. Europe Veterinary Pharmaceuticals Market: Drug Type Estimates & Trend Analysis
6.1. Europe Veterinary Pharmaceuticals Market, Drug Type: Segment Dashboard
6.2. Europe Veterinary Pharmaceuticals Market, Drug Type: Movement Analysis
6.3. Europe Veterinary Pharmaceuticals Market Estimates & Forecasts, Drug Type, 2021 - 2033 (USD Million)
6.4. Branded
6.4.1. Branded Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.5. Generics
6.5.1. Generics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Chapter 7. Europe Veterinary Pharmaceuticals Market: Type Estimates & Trend Analysis
7.1. Europe Veterinary Pharmaceuticals Market, Type: Segment Dashboard
7.2. Europe Veterinary Pharmaceuticals Market, Type: Movement Analysis
7.3. Europe Veterinary Pharmaceuticals Market Estimates & Forecasts, Type, 2021 - 2033 (USD Million)
7.4. Prescription
7.4.1. Prescription Market Estimates and Forecasts, 2021 - 2033 (USD Million)
7.5. OTC
7.5.1. OTC Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Chapter 8. Europe Veterinary Pharmaceuticals Market: Route of Administration Estimates & Trend Analysis
8.1. Europe Veterinary Pharmaceuticals Market, Route of Administration: Segment Dashboard
8.2. Europe Veterinary Pharmaceuticals Market, Route of Administration: Movement Analysis
8.3. Europe Veterinary Pharmaceuticals Market Estimates & Forecasts, Route of Administration, 2021 - 2033 (USD Million)
8.4. Oral
8.4.1. Oral Market Estimates and Forecasts, 2021 - 2033 (USD Million)
8.5. Injectable
8.5.1. Injectable Market Estimates and Forecasts, 2021 - 2033 (USD Million)
8.6. Topical
8.6.1. Topical Market Estimates and Forecasts, 2021 - 2033 (USD Million)
8.7. Other Routes
8.7.1. Other Routes Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Chapter 9. Europe Veterinary Pharmaceuticals Market: Sales Channel Estimates & Trend Analysis
9.1. Europe Veterinary Pharmaceuticals Market, Sales Channel: Segment Dashboard
9.2. Europe Veterinary Pharmaceuticals Market, Sales Channel: Movement Analysis
9.3. Europe Veterinary Pharmaceuticals Market Estimates & Forecasts, Sales Channel, 2021 - 2033 (USD Million)
9.4. Institutional Sales
9.4.1. Institutional Sales Market Estimates and Forecasts, 2021 - 2033 (USD Million)
9.5. Veterinary Pharmacies & Retail
9.5.1. Veterinary Pharmacies & Retail Market Estimates and Forecasts, 2021 - 2033 (USD Million)
9.6. E-Commerce
9.6.1. E-Commerce Market Estimates and Forecasts, 2021 - 2033 (USD Million)
9.7. Other Channels
9.7.1. Other Channels Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Chapter 10. Europe Veterinary Pharmaceuticals Market: Country Estimates & Trend Analysis
10.1. Country Market Dashboard
10.2. Country Market Share Analysis, 2025 & 2033
10.3. Europe
10.3.1. Europe Market Estimates and Forecasts, 2021 - 2033 (USD Million)
10.3.2. UK
10.3.2.1. Key Country Dynamics
10.3.2.2. Competitive Scenario
10.3.2.3. Regulatory Framework
10.3.2.4. UK Market Estimates and Forecasts, 2021 - 2033 (USD Million)
10.3.3. Germany
10.3.3.1. Key Country Dynamics
10.3.3.2. Competitive Scenario
10.3.3.3. Regulatory Framework
10.3.3.4. Germany Market Estimates and Forecasts, 2021 - 2033 (USD Million)
10.3.4. France
10.3.4.1. Key Country Dynamics
10.3.4.2. Competitive Scenario
10.3.4.3. Regulatory Framework
10.3.4.4. France Market Estimates and Forecasts, 2021 - 2033 (USD Million)
10.3.5. Italy
10.3.5.1. Key Country Dynamics
10.3.5.2. Competitive Scenario
10.3.5.3. Regulatory Framework
10.3.5.4. Italy Market Estimates and Forecasts, 2021 - 2033 (USD Million)
10.3.6. Spain
10.3.6.1. Key Country Dynamics
10.3.6.2. Competitive Scenario
10.3.6.3. Regulatory Framework
10.3.6.4. Spain Market Estimates and Forecasts, 2021 - 2033 (USD Million)
10.3.7. Denmark
10.3.7.1. Key Country Dynamics
10.3.7.2. Competitive Scenario
10.3.7.3. Regulatory Framework
10.3.7.4. Denmark Market Estimates and Forecasts, 2021 - 2033 (USD Million)
10.3.8. Sweden
10.3.8.1. Key Country Dynamics
10.3.8.2. Competitive Scenario
10.3.8.3. Regulatory Framework
10.3.8.4. Sweden Market Estimates and Forecasts, 2021 - 2033 (USD Million)
10.3.9. Norway
10.3.9.1. Key Country Dynamics
10.3.9.2. Competitive Scenario
10.3.9.3. Regulatory Framework
10.3.9.4. Norway Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Chapter 11. Competitive Landscape
11.1. Key Participant Categorization
11.1.1. Market Leaders
11.1.2. Emerging Players
11.2. Market Assessment Analysis, 2025 (Heat Map Analysis)
11.3. Company Profiles
11.3.1. Merck & Co., Inc.,
11.3.1.1. Company Overview
11.3.1.2. Financial Performance
11.3.1.3. Product Benchmarking
11.3.1.4. Strategic Initiatives
11.3.2. Ceva
11.3.2.1. Company Overview
11.3.2.2. Financial Performance
11.3.2.3. Product Benchmarking
11.3.2.4. Strategic Initiatives
11.3.3. Vetoquinol
11.3.3.1. Company Overview
11.3.3.2. Financial Performance
11.3.3.3. Product Benchmarking
11.3.3.4. Strategic Initiatives
11.3.4. Zoetis Products LLC
11.3.4.1. Company Overview
11.3.4.2. Financial Performance
11.3.4.3. Product Benchmarking
11.3.4.4. Strategic Initiatives
11.3.5. Boehringer Ingelheim International GmbH
11.3.5.1. Company Overview
11.3.5.2. Financial Performance
11.3.5.3. Product Benchmarking
11.3.5.4. Strategic Initiatives
11.3.6. Elanco
11.3.6.1. Company Overview
11.3.6.2. Financial Performance
11.3.6.3. Product Benchmarking
11.3.6.4. Strategic Initiatives
11.3.7. Virbac
11.3.7.1. Company Overview
11.3.7.2. Financial Performance
11.3.7.3. Product Benchmarking
11.3.7.4. Strategic Initiatives
11.3.8. Calier
11.3.8.1. Company Overview
11.3.8.2. Financial Performance
11.3.8.3. Product Benchmarking
11.3.8.4. Strategic Initiatives
11.3.9. Bimeda Corporate
11.3.9.1. Company Overview
11.3.9.2. Financial Performance
11.3.9.3. Product Benchmarking
11.3.9.4. Strategic Initiatives
11.3.10. Prodivet Pharmaceuticals SA/NV
11.3.10.1. Company Overview
11.3.10.2. Financial Performance
11.3.10.3. Product Benchmarking
11.3.10.4. Strategic Initiatives
11.4. Other Strategic Initiatives
List of Tables
1. List of Secondary Sources
2. List of Abbreviations
3. Europe Veterinary Pharmaceuticals Market, Animal, 2021 - 2033 (USD Million)
4. Europe Veterinary Pharmaceuticals Market, Product, 2021 - 2033 (USD Million)
5. Europe Veterinary Pharmaceuticals Market, Drug Type, 2021 - 2033 (USD Million)
6. Europe Veterinary Pharmaceuticals Market, Type, 2021 - 2033 (USD Million)
7. Europe Veterinary Pharmaceuticals Market, Route of Administration, 2021 - 2033 (USD Million)
8. Europe Veterinary Pharmaceuticals Market, Sales Channel, 2021 - 2033 (USD Million)
9. Germany Veterinary Pharmaceuticals Market, Animal, 2021 - 2033 (USD Million)
10. Germany Veterinary Pharmaceuticals Market, Product, 2021 - 2033 (USD Million)
11. Germany Veterinary Pharmaceuticals Market, Drug Type, 2021 - 2033 (USD Million)
12. Germany Veterinary Pharmaceuticals Market, Type, 2021 - 2033 (USD Million)
13. Germany Veterinary Pharmaceuticals Market, Route of Administration, 2021 - 2033 (USD Million)
14. Germany Veterinary Pharmaceuticals Market, Sales Channel, 2021 - 2033 (USD Million)
15. UK Veterinary Pharmaceuticals Market, Animal, 2021 - 2033 (USD Million)
16. UK Veterinary Pharmaceuticals Market, Product, 2021 - 2033 (USD Million)
17. UK Veterinary Pharmaceuticals Market, Drug Type, 2021 - 2033 (USD Million)
18. UK Veterinary Pharmaceuticals Market, Type, 2021 - 2033 (USD Million)
19. UK Veterinary Pharmaceuticals Market, Route of Administration, 2021 - 2033 (USD Million)
20. UK Veterinary Pharmaceuticals Market, Sales Channel, 2021 - 2033 (USD Million)
21. France Veterinary Pharmaceuticals Market, Animal, 2021 - 2033 (USD Million)
22. France Veterinary Pharmaceuticals Market, Product, 2021 - 2033 (USD Million)
23. France Veterinary Pharmaceuticals Market, Drug Type, 2021 - 2033 (USD Million)
24. France Veterinary Pharmaceuticals Market, Type, 2021 - 2033 (USD Million)
25. France Veterinary Pharmaceuticals Market, Route of Administration, 2021 - 2033 (USD Million)
26. France Veterinary Pharmaceuticals Market, Sales Channel, 2021 - 2033 (USD Million)
27. Italy Veterinary Pharmaceuticals Market, Animal, 2021 - 2033 (USD Million)
28. Italy Veterinary Pharmaceuticals Market, Product, 2021 - 2033 (USD Million)
29. Italy Veterinary Pharmaceuticals Market, Drug Type, 2021 - 2033 (USD Million)
30. Italy Veterinary Pharmaceuticals Market, Type, 2021 - 2033 (USD Million)
31. Italy Veterinary Pharmaceuticals Market, Route of Administration, 2021 - 2033 (USD Million)
32. Italy Veterinary Pharmaceuticals Market, Sales Channel, 2021 - 2033 (USD Million)
33. Spain Veterinary Pharmaceuticals Market, Animal, 2021 - 2033 (USD Million)
34. Spain Veterinary Pharmaceuticals Market, Product, 2021 - 2033 (USD Million)
35. Spain Veterinary Pharmaceuticals Market, Drug Type, 2021 - 2033 (USD Million)
36. Spain Veterinary Pharmaceuticals Market, Type, 2021 - 2033 (USD Million)
37. Spain Veterinary Pharmaceuticals Market, Route of Administration, 2021 - 2033 (USD Million)
38. Spain Veterinary Pharmaceuticals Market, Sales Channel, 2021 - 2033 (USD Million)
39. Denmark Veterinary Pharmaceuticals Market, Animal, 2021 - 2033 (USD Million)
40. Denmark Veterinary Pharmaceuticals Market, Product, 2021 - 2033 (USD Million)
41. Denmark Veterinary Pharmaceuticals Market, Drug Type, 2021 - 2033 (USD Million)
42. Denmark Veterinary Pharmaceuticals Market, Type, 2021 - 2033 (USD Million)
43. Denmark Veterinary Pharmaceuticals Market, Route of Administration, 2021 - 2033 (USD Million)
44. Denmark Veterinary Pharmaceuticals Market, Sales Channel, 2021 - 2033 (USD Million)
45. Sweden Veterinary Pharmaceuticals Market, Animal, 2021 - 2033 (USD Million)
46. Sweden Veterinary Pharmaceuticals Market, Product, 2021 - 2033 (USD Million)
47. Sweden Veterinary Pharmaceuticals Market, Drug Type, 2021 - 2033 (USD Million)
48. Sweden Veterinary Pharmaceuticals Market, Type, 2021 - 2033 (USD Million)
49. Sweden Veterinary Pharmaceuticals Market, Route of Administration, 2021 - 2033 (USD Million)
50. Sweden Veterinary Pharmaceuticals Market, Sales Channel, 2021 - 2033 (USD Million)
51. Norway Veterinary Pharmaceuticals Market, Animal, 2021 - 2033 (USD Million)
52. Norway Veterinary Pharmaceuticals Market, Product, 2021 - 2033 (USD Million)
53. Norway Veterinary Pharmaceuticals Market, Drug Type, 2021 - 2033 (USD Million)
54. Norway Veterinary Pharmaceuticals Market, Type, 2021 - 2033 (USD Million)
55. Norway Veterinary Pharmaceuticals Market, Route of Administration, 2021 - 2033 (USD Million)
56. Norway Veterinary Pharmaceuticals Market, Sales Channel, 2021 - 2033 (USD Million)
List of Figures
Figure 1 Market research process
Figure 2 Information Procurement
Figure 3 Primary Research Pattern
Figure 4 Market Research Approaches
Figure 5 Value Chain-Based Sizing & Forecasting
Figure 6 Market Formulation & Validation
Figure 7 Europe Veterinary Pharmaceuticals Market, Market Segmentation
Figure 8 Market Driver Relevance Analysis (Current & Future Impact)
Figure 9 Market Restraint Relevance Analysis (Current & Future Impact)
Figure 10 Market Challenge Relevance Analysis (Current & Future Impact)
Figure 11 PESTEL Analysis
Figure 12 Porter’s Five Forces Analysis
Figure 13 Regional Marketplace: Key Takeaways
Figure 14 Europe Veterinary Pharmaceuticals Market, Animal, 2021 - 2033 (USD Million)
Figure 15 Europe Veterinary Pharmaceuticals Market, Production Animals, 2021 - 2033 (USD Million)
Figure 16 Europe Veterinary Pharmaceuticals Market, Poultry, 2021 - 2033 (USD Million)
Figure 17 Europe Veterinary Pharmaceuticals Market, Swine, 2021 - 2033 (USD Million)
Figure 18 Europe Veterinary Pharmaceuticals Market, Bovine, 2021 - 2033 (USD Million)
Figure 19 Europe Veterinary Pharmaceuticals Market, Ovine & Caprine, 2021 - 2033 (USD Million)
Figure 20 Europe Veterinary Pharmaceuticals Market, Other Production Animals, 2021 - 2033 (USD Million)
Figure 21 Europe Veterinary Pharmaceuticals Market, Companion Animals, 2021 - 2033 (USD Million)
Figure 22 Europe Veterinary Pharmaceuticals Market, Canine, 2021 - 2033 (USD Million)
Figure 23 Europe Veterinary Pharmaceuticals Market, Feline, 2021 - 2033 (USD Million)
Figure 24 Europe Veterinary Pharmaceuticals Market, Equine, 2021 - 2033 (USD Million)
Figure 25 Europe Veterinary Pharmaceuticals Market, Other Companion Animals, 2021 - 2033 (USD Million)
Figure 26 Europe Veterinary Pharmaceuticals Market, Product, 2021 - 2033 (USD Million)
Figure 27 Europe Veterinary Pharmaceuticals Market, Parasiticides, 2021 - 2033 (USD Million)
Figure 28 Europe Veterinary Pharmaceuticals Market, Anti-infectives, 2021 - 2033 (USD Million)
Figure 29 Europe Veterinary Pharmaceuticals Market, Anti-inflammatory, 2021 - 2033 (USD Million)
Figure 30 Europe Veterinary Pharmaceuticals Market, Analgesics, 2021 - 2033 (USD Million)
Figure 31 Europe Veterinary Pharmaceuticals Market, Other Products, 2021 - 2033 (USD Million)
Figure 32 Europe Veterinary Pharmaceuticals Market, Drug Type, 2021 - 2033 (USD Million)
Figure 33 Europe Veterinary Pharmaceuticals Market, Branded, 2021 - 2033 (USD Million)
Figure 34 Europe Veterinary Pharmaceuticals Market, Generics, 2021 - 2033 (USD Million)
Figure 35 Europe Veterinary Pharmaceuticals Market, Type, 2021 - 2033 (USD Million)
Figure 36 Europe Veterinary Pharmaceuticals Market, Prescription, 2021 - 2033 (USD Million)
Figure 37 Europe Veterinary Pharmaceuticals Market, OTC, 2021 - 2033 (USD Million)
Figure 38 Europe Veterinary Pharmaceuticals Market, Route of Administration, 2021 - 2033 (USD Million)
Figure 39 Europe Veterinary Pharmaceuticals Market, Oral, 2021 - 2033 (USD Million)
Figure 40 Europe Veterinary Pharmaceuticals Market, Injectable, 2021 - 2033 (USD Million)
Figure 41 Europe Veterinary Pharmaceuticals Market, Topical, 2021 - 2033 (USD Million)
Figure 42 Europe Veterinary Pharmaceuticals Market, Other Routes, 2021 - 2033 (USD Million)
Figure 43 Europe Veterinary Pharmaceuticals Market, Sales Channel, 2021 - 2033 (USD Million)
Figure 44 Europe Veterinary Pharmaceuticals Market, Institutional Sales, 2021 - 2033 (USD Million)
Figure 45 Europe Veterinary Pharmaceuticals Market, Veterinary Pharmacies & Retail, 2021 - 2033 (USD Million)
Figure 46 Europe Veterinary Pharmaceuticals Market, E-Commerce, 2021 - 2033 (USD Million)
Figure 47 Europe Veterinary Pharmaceuticals Market, Other Channels, 2021 - 2033 (USD Million)
Figure 48 Country Outlook, 2025 & 2033
Figure 49 Veterinary Pharmaceuticals Market, 2021 - 2033 (USD Million)
Figure 50 Key Country Dynamics
Figure 51 UK Veterinary Pharmaceuticals Market, 2021 - 2033 (USD Million)
Figure 52 Key Country Dynamics
Figure 53 Germany Veterinary Pharmaceuticals Market, 2021 - 2033 (USD Million)
Figure 54 Key Country Dynamics
Figure 55 France Veterinary Pharmaceuticals Market, 2021 - 2033 (USD Million)
Figure 56 Key Country Dynamics
Figure 57 Italy Veterinary Pharmaceuticals Market, 2021 - 2033 (USD Million)
Figure 58 Key Country Dynamics
Figure 59 Spain Veterinary Pharmaceuticals Market, 2021 - 2033 (USD Million)
Figure 60 Key Country Dynamics
Figure 61 Denmark Veterinary Pharmaceuticals Market, 2021 - 2033 (USD Million)
Figure 62 Key Country Dynamics
Figure 63 Sweden Veterinary Pharmaceuticals Market, 2021 - 2033 (USD Million)
Figure 64 Key Country Dynamics
Figure 65 Norway Veterinary Pharmaceuticals Market, 2021 - 2033 (USD Million)

Companies Mentioned

  • Merck & Co., Inc.,
  • Ceva
  • Vetoquinol
  • Zoetis Services LLC
  • Boehringer Ingelheim International GmbH
  • Elanco
  • Virbac
  • Calier
  • Bimeda Corporate
  • Prodivet Pharmaceuticals SA/NV